Cellartis
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Maclagan House 1 Würzburg Connecticut, D...Phone Number
+44 1382568333Website
www.cellartis.comRevenue
$6.9 MillionIndustry
About Cellartis
Is Cellartis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cellartis had a recent Job posting/layoffs
Earning: See what the market has to say on Cellartis recently announced quarterly report
Check out if Cellartis is spiking on competitors!
Check if Cellartis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cellartis launches new products
Congratulate Masked Content for being promoted to Masked Content at Cellartis
Cellartis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cellartis has new funding data
Recommended Actions
Find VP level buyers at Cellartis
Find 2 more new buyers
Compare Similar Companies to Cellartis
Compare insights from companies similar to Cellartis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cellartis
Company Profile Activity
Activity Insights
Cellartis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellartis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellartis.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellartis
Cellartis AB is a premier provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery to... Read More